Injuries to the anterior cruciate ligament (ACL) and the meniscus are very common. Both the ACL and the meniscus play a crucial role in the complex biomechanics of the knee and operative treatment is often necessary. For example, in the US approximately 200,000 ACL reconstructions are performed annually. Usually, autogenous tendons like the mid-third of the patellar tendon or the hamstring tendons (semitendinosus/gracilis) are used. Nevertheless, the availability of autogenous tendons for ACL reconstruction is limited as well as the possibilities of meniscus repair. Ligament and meniscus allografts often show problems regarding long-term stability, immunological reactions and possible transmission of infectious diseases, whereas synthetic materials can cause foreign body reactions and often lack good initial biomechanical stability or fail to maintain long-term stability. The idea of acellularizing ligaments and meniscus cartilage has arisen to remove the immunogenic cells to reduce the adverse immunological reactions. By preserving the extracellular matrix (e. g. collagen, glycosaminoglycans, proteoglycans), the main biomechanical properties are preserved and the so obtained scaffolds provide a natural environment for the ingrowing cells. The acellular scaffolds can be used as a scaffold for in vivo repopulation or can be seeded with autologous cells in vitro before implantation using different cell sources. By this, further improvement of the biochemical and biomechanical properties as well as the remodelling of the graft could be improved. In the meantime, a variety of different methods has been described to acellularize tissues reaching from repetitive freezing/ thawing over the use of hydrostatic high pressure to different chemical methods. Only by chemical means are the cells actually removed. In terms of chemical acellularization, SDS (sodium dodecyl sulphate), Triton-X or TnbP (trinitro-butyl-phosphate) are the most popular substances, with SDS being the strongest cell removal agent for tendon and meniscus tissue. As in vitro tests have shown, tissue processing using SDS does not influence the biomechanical properties, while all cells -being responsible for the immunological effects -are removed. However, more research using in vivo animal experiments has to be performed before application in humans is possible.
22www.intechopen.com
Tissue Engineering 438This tissue engineering strategy might be suitable to satisfy the increasing demand for tissue engineered tissue coming along with the increased patients´ demands in the future.